Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia

Published:2024-05-03 Issue:4-5 Volume:17 Page:103-106
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Reikvam Håkon¹²,Dillon Richard³

Affiliation:

1. K.G. Jebsen Center for Myeloid Blood Cancer, Department of Clinical Science, University of Bergen, Bergen, Norway

2. Department of Medicine, Haukeland University Hospital, Bergen, Norway

3. Department of Medical and Molecular Genetics, King’s College, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Funder

no relevant affiliations or financial

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2024.2347303

Reference23 articles.

1. Acute myeloid leukaemia

2. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

3. Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia

4. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

5. The present and future of measurable residual disease testing in acute myeloid leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP